Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Clinical trial NCT00454480 · COMPLETED
Trial details
- NCT number
- NCT00454480
- Sponsor
- The University of New South Wales
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2012-08-01
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.